A new Jefferies research report makes the case that while market parameters are indeed expensive, there still are cheap stocks to buy that have a large enough market cap to provide some…
24/7 Wall St. has put together a preview of AT&T, AbbVie, Starbucks and some of the major companies scheduled to share their quarterly results in the coming days.
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials.
The December 15 short interest data have been compared with the previous figures, and short interest increased in most of these selected pharmaceutical stocks.
A top new addition to the Franchise list portfolio and three additional dividend stocks that the Jefferies team views as their top high conviction picks.
The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected pharmaceutical stocks.
With money expected to come out of the bond market, these four stocks are an attractive alternative that have solid upside potential, and they are the highest conviction picks at Jefferies.
The November 15 short interest data have been compared with the previous figures, and short interest was mixed in the selected pharmaceutical stocks.
With earnings for the third quarter over, and the fourth quarter of 2016 in full swing, many of the top companies we follow on Wall Street are making some changes to the…
Drug prices have been under pressure due to the campaign rhetoric, and short interest has increased in most of these selected pharmaceutical stocks.
In a recent research note, the analysts at Jefferies make a big move by removing a top medical devices company from the firm's well-respected Franchise Picks list of stocks.
The relentless populist rhetoric has lowered the prices on some of the top pharmaceutical companies, and long-term growth and income investors have a chance to buy some great stocks on sale.
The top analyst upgrades, downgrades and initiations seen on Monday morning include AbbVie, Chevron, Home Depot, Nike, Qualcomm and VMware.
AbbVie reported mixed third-quarter financial results and a dividend hike before the markets opened on Friday.
Chris Lange Four companies in four very different sectors that all offer liquidity, a degree of safety and solid dividends that should continue to rise.
